United States · FDA National Drug Code directory
NAPROXEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51655-621_494f2182-140c-e7cc-e063-6394a90a093a
- Product NDC
- 51655-621
- Form
- TABLET
- Composition / generic term
- NAPROXEN
- Labeler
- Northwind Health Company, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200706
- Source listing expiry
- 20271231
Source-listed ingredients
- NAPROXEN — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET in 1 BOTTLE, PLASTIC (51655-621-20) · 51655-621-20
- 60 TABLET in 1 BOTTLE, PLASTIC (51655-621-25) · 51655-621-25
- 180 TABLET in 1 BOTTLE, PLASTIC (51655-621-83) · 51655-621-83
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →